Learning From the Past & Harnessing Design Innovation to Develop a New Wave of ADCs
- Contextualizing success from cytotoxic ADC development, headlined by the approval and success of Padcev
- Re-envisioning ADC design through collaboration on dual payload ADC development
- Demonstrating ADC payload innovation through degrader antibody conjugate programs